Transparency, Communication Essential To Sunscreen TEA Review Process – FDA
This article was originally published in The Rose Sheet
Executive Summary
CDER delivers draft guidances on formatting TEAs, withdrawing applications and requesting an advisory committee review along with its draft on the safety and effectiveness data needed to determine whether OTC sunscreen active ingredients should be added to the monograph.